These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24586085)

  • 1. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.
    Reyngold M; Niland J; ter Veer A; Milne D; Bekaii-Saab T; Cohen SJ; Lai L; Schrag D; Skibber JM; Small W; Weiser M; Wilkinson N; Goodman KA
    J Natl Compr Canc Netw; 2014 Feb; 12(2):235-43. PubMed ID: 24586085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 3. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
    Khrizman P; Niland JC; ter Veer A; Milne D; Bullard Dunn K; Carson WE; Engstrom PF; Shibata S; Skibber JM; Weiser MR; Schrag D; Benson AB
    J Clin Oncol; 2013 Jan; 31(1):30-8. PubMed ID: 23169502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
    Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
    J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients.
    Zhao F; Wang J; Yu H; Cheng X; Li X; Zhu X; Xu X; Lin J; Chen X; Yan S
    Radiat Oncol; 2020 Feb; 15(1):49. PubMed ID: 32103755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of neoadjuvant radiotherapy on anastomotic leak after restorative resection for rectal cancer.
    Nisar PJ; Lavery IC; Kiran RP
    J Gastrointest Surg; 2012 Sep; 16(9):1750-7. PubMed ID: 22744637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
    Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
    Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
    Wasmuth HH; Rekstad LC; Tranø G
    Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.
    Patel SV; Roxburgh CS; Vakiani E; Shia J; Smith JJ; Temple LK; Paty P; Garcia-Aguilar J; Nash G; Guillem J; Wu A; Reyngold M; Weiser MR
    J Surg Oncol; 2016 Oct; 114(5):637-641. PubMed ID: 27641934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?
    Holubar SD; Brickman RK; Greaves SW; Ivatury SJ
    J Am Coll Surg; 2016 Aug; 223(2):291-8. PubMed ID: 27112126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.